The Association Between Obesity and Visit-to-Visit Variability in Systolic Blood Pressure: A Prospective Study

1. Rahimi K, Emdin CA, MacMahon S. The epidemiology of blood pressure and its worldwide management. Circ Res. 2015; 116(6):925-936.10.1161/CIRCRESAHA.116.30472325767281Search in Google Scholar

2. WHO Global Health Observatory Data Repository [online database]. Geneva, World Health Organization, 2013. (Accessed May 21, 2013, at site http://apps.who.int/gho/data/view.main).Search in Google Scholar

3. Djordjic V, Radisavljevic S, Milanovic I, Bozic P, Grbic M, Jorga J, Ostojic SM. WHO European Childhood Obesity Surveillance Initiative in Serbia: a prevalence of overweight and obesity among 6-9-year-old school children. J Pediatr Endocrinol Metab. 2016; 29(9):1025-1030.10.1515/jpem-2016-013827544722Search in Google Scholar

4. Bluher M. Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab. 2013; 27(2):163-177.10.1016/j.beem.2013.02.00523731879Search in Google Scholar

5. Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease. JRSM Cardiovasc Dis. 2016; 5:2048004016633371.Search in Google Scholar

6. Nakamura K, Fuster JJ, Walsh K. Adipokines: A link between obesity and cardiovascular disease. Journal of human hypertension. 2014; 63(4): 250–259.Search in Google Scholar

7. Seimon RV, Espinoza D, Ivers L, Gebski V, Finer N, Legler UF, Sharma AM, James WP, Coutinho W, Caterson ID. Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease. Int J Obes (Lond). 2014; 38(9):1165-1171.10.1038/ijo.2014.224406481Search in Google Scholar

8. Hall JE, Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms Circ Res. 2015; 116(6):991-1006.Search in Google Scholar

9. Bluher M. The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 2010; 21(1):38–43.10.1097/MOL.0b013e3283346ccc19915462Search in Google Scholar

10. Bluher M. Are there still healthy obese patients? Curr Opin Endocrinol Diabetes Obes 2012; 19(5):341–346.Search in Google Scholar

11. Diaz KM, Tanner RM, Falzon L, Levitan EB, Reynolds K, Shimbo D, Muntner P. Visit-to-Visit Variability of Blood Pressure and Cardiovascular Disease and All-Cause Mortality. A Systematic Review and Meta-Analysis. Hypertension. 2014; 64(5):965-982.10.1161/HYPERTENSIONAHA.114.03903421725125069669Search in Google Scholar

12. Wang A, Li Z, Yang Y, Chen G, Wang C, Wu Y, Ruan C, Liu Y, Wang Y, Wu S. Impact of baseline systolic blood pressure on visit-to-visit blood pressure variability: the Kailuan study. Ther Clin Risk Manag. 2016; 12:1191-1196.10.2147/TCRM.S112082497710427536123Search in Google Scholar

13. Blacher J, Safar ME, Ly C, Szabo de Edelenyi F, Hercberg S, Galan P. Blood pressure variability: cardiovascular risk integrator or independent risk factor? J Hum Hypertens. 2015; 29(2):122-126.10.1038/jhh.2014.4424990422Search in Google Scholar

14. Faramawi MF, Fischbach L, Delongchamp R, Cardenas V, Abouelenien S, Chedjieu IP, Taha N. Obesity is associated with visit-to-visit systolic blood pressure variability in the US adults. J Public Health (Oxf). 2015; 37(4):694–700.Search in Google Scholar

15. Tadic M, Cuspidi C, Vukomanovic V, Kocijancic V, Celic V, Stanisavljevic D. The Association between Obesity, Blood Pressure Variability, and Right Ventricular Function and Mechanics in Hypertensive Patients. J Am Soc Echocardiogr. 2016; 29(8):802-811.10.1016/j.echo.2016.04.00127170542Search in Google Scholar

16. Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25(6):1105-1187.10.1097/HJH.0b013e3281fc975a17563527Search in Google Scholar

17. Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, Toplak H. European Guidelines for Obesity Management in Adults. Obes Facts. 2015; 8(6):402-424.10.1159/000442721Search in Google Scholar

18. Schmieder RE, Messerli FH. Does obesity influence early target organ damage in hypertensive patients? Circulation 1993; 87(5):1482-1482.Search in Google Scholar

19. Kannel WB, Zhang T, Garrison RJ. Is obesity related hypertension less of a cardiovascular risk? The Framingham Study. Am Heart J 1990; 120(5):1195-1201.10.1016/0002-8703(90)90136-LSearch in Google Scholar

20. Juhanoja EP, Niiranen TJ, Johansson JK, Puukka PJ, Jula AM. Agreement between ambulatory, home, and office blood pressure variability. J Hypertens. 2016; 34(1):61-67.10.1097/HJH.000000000000077226630214Search in Google Scholar

21. Levitan EB, Kaciroti N, Oparil S, Julius S, Muntner P. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens 2013; 27(10):589–593.10.1038/jhh.2013.1923535987Search in Google Scholar

22. Tai C, Sun Y, Dai N, Xu D, Chen W, Wang J. Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77,299 patients. Hypertens (Greenwich). 2015; 17(2):107-115.10.1111/jch.12484803198325644682Search in Google Scholar

23. Poorolajal J, Hooshmand E, Bahrami M, Ameri P. How much excess weight loss can reduce the risk of hypertension? Public Health (Oxf) 2016; 133:14-18.Search in Google Scholar

24. Luo WS, Guo ZR, Hu X, Zhou ZY, Wu M, Zhang LJ, Liu JC. Impact of dynamic change of waist circumference or body mass index in hypertension incidence. Zhonghua Yu Fang Yi Xue Za Zhi. 2011; 45(11):1012-1016Search in Google Scholar

25. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, Polo FH, Grassi G, Sega R. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension. 2007; 49(6):1265-1270.10.1161/HYPERTENSIONAHA.107.08870817452502Search in Google Scholar

26. Yano Y, Vongpatanasin W, Ayers C, Turer A, Chandra A, Carnethon MR, Greenlad P, de Lemos JA, Neeland IJ. Regional Fat Distribution and Blood Pressure Level and Variability. The Dallas Heart Study J. Neeland Hypertension. 2016; 68(3):576-583.10.1161/HYPERTENSIONAHA.116.07876498281427432862Search in Google Scholar

27. Jones A, Charakida M, Falaschetti E, Hingorani AD, Finer N, Masi S, Donald AE, Lawlor DA, Smith GD, Deanfield JE. Adipose and height growth through childhood and blood pressure status in a large prospective cohort study. Hypertension. 2012; 59(5):919–925.10.1161/HYPERTENSIONAHA.111.187716342892322493074Search in Google Scholar

28. Tu W, Eckert GJ, DiMeglio LA, Yu Z, Jung J, Pratt JH. Intensified effect of adiposity on blood pressure in overweight and obese children. Hypertension. 2011; 58:818– 824.10.1161/HYPERTENSIONAHA.111.175695343339721968752Search in Google Scholar

29. Raitakari M, Ilvonen T, Ahotupa M, Lehtimaki T, Harmoinen A, Suominen P, Juhani LE, Jaakko H, Olli TR. Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol. 2004; 24:124–128.10.1161/01.ATV.0000109749.11042.7c14656740Search in Google Scholar

30. Choe SS, Huh YJ, Hwang IJ, Kim JI, Kim JB. Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders. Front Endocrinol (Lausanne) 2016; 7:30.10.3389/fendo.2016.00030482958327148161Search in Google Scholar

31. Siebenhofer A, Jeitler K, Horvath K, Berghold A, Siering U, Semlitsch T. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database Syst Rev 2013; (3):CD007654.10.1002/14651858.CD007654.pub323543553Search in Google Scholar

32. Leoncini G, Viazzi F, Storace G, Deferrari G, Pontremoli R. Blood pressure variability and multiple organ damage in primary hypertension. J Hum Hypertens. 2013; 27:663–670.10.1038/jhh.2013.4523739158Search in Google Scholar

33. Mulè G, Calcaterra I, Costanzo M, Geraci G, Guarino L, Foraci AC, Vario MG, Cerasola G, Cottone S. Relationship between short-term blood pressure variability and subclinical renal damage in essential hypertensive patients. J Clin Hypertens (Greenwich). 2015; 17(6):473– 480.10.1111/jch.12534803179925808042Search in Google Scholar